Anna R. Giuliano, PhD, serves as the President of the International Papillomavirus Society (IPVS) and is the founding director of the Center for Immunization and Infection Research in Cancer (CIIRC) at the Moffitt Cancer Center. A pioneer in cancer research, her groundbreaking work has significantly advanced our understanding of human papillomavirus (HPV) and its role in multiple cancers.

Dr. Giuliano began her career focusing on the relationship between HPV infections and cervical cancer in women. Over the past several decades, her research has expanded to include HPV-related penile, anal, and oral cancers in men, as well as other infectious diseases and their links to cancer. Her work has provided critical insights into how HPV infections are acquired and cleared, the proportion that progress to disease, and the effectiveness of HPV vaccines in protecting against multiple diseases in both women and men.

An esteemed expert in cancer epidemiology and prevention, Dr. Giuliano has been continuously funded by the National Institutes of Health (NIH) since 1990. She has conducted extensive studies among diverse populations in the United States and internationally, contributing to landmark reports such as the 1999 Institute of Medicine (IOM) publication The Unequal Burden of Cancer and the 2005 International Agency for Research on Cancer (IARC) report, which established HPV as a cause of multiple cancers in women and men.

In recognition of her contributions to cancer prevention and research, Dr. Giuliano received the prestigious American Cancer Society (ACS) Distinguished Achievement in Cancer Award in 2013 during the ACS’s 100th anniversary. In 2018, she was honored with the ACS Clinical Research Professor Award for her work in the prevention of infection-related cancers.

With over 400 peer-reviewed publications, Dr. Giuliano continues to influence the field of cancer research, advancing our understanding of infection-related cancers and their prevention.

Learn more about Dr. Giuliano’s contributions here.